International study on inter-reader variability for circulating tumor cells in breast cancer.

Ignatiadis, Michail; Riethdorf, Sabine; Bidard, François-Clément; Vaucher, Isabelle; Khazour, Mustapha; Rothé, Françoise; Metallo, Jessica; Rouas, Ghizlane; Payne, Rachel E; Coombes, Raoul Charles; Teufel, Ingrid; Andergassen, Ulrich; Apostolaki, Stella; Politaki, Eleni; Mavroudis, Dimitris; Bessi, Silvia; Pestrin, Marta; Di Leo, Angelo; Campion, Michael; Reinholz, Monica; Perez, Edith A; Piccart-Gebhart, Martine; Borgen, E; Naume, Bjorn; Jiménez, José Antonio; Aura, Claudia Monica; Zorzino, Laura; Cassatella, Maria Cristina; Sandri, Maria Teresa; Mostert, Bianca; Sleijfer, Stefan; Kraan, Jaco; Janni, Wolfgang; Fehm, Tanja; Rack, B; Terstappen, LWMM; Repollet, Madeline; Pierga, Jean-Yves; Miller, Craig; Sotiriou, Christos; Michiels, Stefan; Pantel, Klaus

doi:doi/10.1186/bcr3647

Recherche avancée | Historique de recherche Mon DI-fusion | À propos de DI-fusion | Contact |

Citer

International study on inter-reader variability for circulating tumor cells in breast cancer.

Article révisé par les pairs

Résumé :

Circulating tumor cells (CTCs) have been studied in breast cancer with the CellSearch(R) system. Given the low CTC counts in non-metastatic breast cancer, it is important to evaluate the inter-reader agreement.

Documents en relation

DI-fusion

Circulating tumor DNA validity and potential uses in metastatic breast cancer
par Amato, Ottavia , Giannopoulou, Nefeli , Ignatiadis, Michail
Publication 2024-12
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
par Rediti, Mattia , Venet, David , Joaquin Garcia, Andrea , Maetens, Marion M. , Vincent, Delphine , Majjaj, Samira , El-abed, Sarra , Di Cosimo, Serena , Ueno, Takayuki , Izquierdo, Miguel , Piccart-Gebhart, Martine , Pusztai, Lajos , Loi, Sherene , Salgado, Roberto , Viale, Giuseppe , Rothé, Françoise , Sotiriou, Christos
Publication 2024-12-01
Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.
par Wang, Xiaoxiao , Venet, David , Lifrange, Frédéric , Larsimont, Denis , Rediti, Mattia , Stenbeck, Linnea , Dupont, Floriane , Rouas, Ghizlane , Garcia, Andrea Joaquin , Craciun, Ligia , Buisseret, Laurence , Ignatiadis, Michail , Carausu, Marcela , Bhalla, Nayanika , Masarapu, Yuvarani , Villacampa, Eva Gracia , Franzén, Lovisa , Saarenpää, Sami , Kvastad, Linda , Thrane, Kim , Lundeberg, Joakim , Rothé, Françoise , Sotiriou, Christos
Publication 2024-11
The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab
par Buisseret, Laurence , Bareche, Yacine , Venet, David , Girard, Edwina , Gombos, Andrea , Emonts, Patrick , Majjaj, Samira , Rouas, Ghizlane , Serra, Matteo , Debien, Véronique , Agostinetto, Elisa , Garaud, Soizic , Willard-Gallo, Karen , Larsimont, Denis , Stagg, John , Rothé, Françoise , Sotiriou, Christos
Publication 2024-05-01
Emerging treatments in HER2-positive advanced breast cancer: Keep raising the bar
par Agostinetto, Elisa , Curigliano, Giuseppe , Piccart-Gebhart, Martine
Publication 2024-06

Référencement	Visibilité	Pérennité	Facilité
Les publications encodées constituent la bibliographie académique de l'Université.	Les documents déposés sont indexés par les moteurs de recherche (Google Scholar,…).	Les documents déposés en open-access sont archivés au sein du réseau de préservation SAFE-PLN (www.safepln.org).	Les listes de publications sont compatibles avec le CV-ULB, le FNRS et accessibles sur le web.